130 related articles for article (PubMed ID: 30539832)
21. A study of the dosimetric characteristics between different fixed-field IMRT and VMAT in early-stage primary mediastinal B-cell lymphoma.
Xu LM; Kang ML; Jiang B; Liu QF; Li YX
Med Dosim; 2018 Spring; 43(1):91-99. PubMed ID: 28935521
[TBL] [Abstract][Full Text] [Related]
22.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
23. Dosimetric advantage of intensity-modulated radiotherapy for whole ventricles in the treatment of localized intracranial germinoma.
Sakanaka K; Mizowaki T; Hiraoka M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e273-80. PubMed ID: 21640515
[TBL] [Abstract][Full Text] [Related]
24. Volumetric modulation arc radiotherapy with flattening filter-free beams compared with static gantry IMRT and 3D conformal radiotherapy for advanced esophageal cancer: a feasibility study.
Nicolini G; Ghosh-Laskar S; Shrivastava SK; Banerjee S; Chaudhary S; Agarwal JP; Munshi A; Clivio A; Fogliata A; Mancosu P; Vanetti E; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):553-60. PubMed ID: 22386376
[TBL] [Abstract][Full Text] [Related]
25. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
[TBL] [Abstract][Full Text] [Related]
26. Dosimetric and clinical outcomes of involved-field intensity-modulated radiotherapy after chemotherapy for early-stage Hodgkin's lymphoma with mediastinal involvement.
Lu NN; Li YX; Wu RY; Zhang XM; Wang WH; Jin J; Song YW; Fang H; Ren H; Wang SL; Liu YP; Liu XF; Chen B; Dai JR; Yu ZH
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):210-6. PubMed ID: 22436783
[TBL] [Abstract][Full Text] [Related]
27. Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.
Hoppe BS; Flampouri S; Su Z; Morris CG; Latif N; Dang NH; Lynch J; Li Z; Mendenhall NP
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):260-7. PubMed ID: 22014950
[TBL] [Abstract][Full Text] [Related]
28. The promising outcome with simultaneous integrated boost intensity modulated radiotherapy in confined nasal extranodal NK/T-cell lymphoma.
Song Y; Li J; Wang S; Zhou Z; Qiao X; Zhao X
Leuk Lymphoma; 2021 Dec; 62(12):2907-2914. PubMed ID: 34261418
[TBL] [Abstract][Full Text] [Related]
29. Compared with intensity-modulated radiotherapy, image-guided radiotherapy reduces severity of acute radiation-induced skin toxicity during radiotherapy in patients with breast cancer.
Lin JC; Tsai JT; Chou YC; Li MH; Liu WH
Cancer Med; 2018 Aug; 7(8):3622-3629. PubMed ID: 29968974
[TBL] [Abstract][Full Text] [Related]
30. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
31. Improvement in toxicity in high risk prostate cancer patients treated with image-guided intensity-modulated radiotherapy compared to 3D conformal radiotherapy without daily image guidance.
Sveistrup J; af Rosenschöld PM; Deasy JO; Oh JH; Pommer T; Petersen PM; Engelholm SA
Radiat Oncol; 2014 Feb; 9():44. PubMed ID: 24495815
[TBL] [Abstract][Full Text] [Related]
32. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and conventional intensity-modulated radiotherapy in locally advanced non-small-cell lung cancer: a retrospective study.
Wang D; Bi N; Zhang T; Zhou Z; Xiao Z; Liang J; Chen D; Hui Z; Lv J; Wang X; Wang X; Deng L; Wang W; Wang J; Wang C; Lu X; Xu K; Wu L; Xue W; Feng Q; Wang L
Radiat Oncol; 2019 Jun; 14(1):106. PubMed ID: 31196118
[TBL] [Abstract][Full Text] [Related]
33. Dosimetric benefits of IMRT and VMAT in the treatment of middle thoracic esophageal cancer: is the conformal radiotherapy still an alternative option?
Wu Z; Xie C; Hu M; Han C; Yi J; Zhou Y; Yuan H; Jin X
J Appl Clin Med Phys; 2014 May; 15(3):93–101. PubMed ID: 24892336
[TBL] [Abstract][Full Text] [Related]
34. Correlation between the γ passing rates of IMRT plans and the volumes of air cavities and bony structures in head and neck cancer.
Shen Z; Tan X; Li S; Tian X; Luo H; Wang Y; Jin F
Radiat Oncol; 2021 Jul; 16(1):134. PubMed ID: 34289863
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiotherapy for sinonasal cancer: improved outcome compared to conventional radiotherapy.
Dirix P; Vanstraelen B; Jorissen M; Vander Poorten V; Nuyts S
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):998-1004. PubMed ID: 20338694
[TBL] [Abstract][Full Text] [Related]
36. Temporally feathered intensity-modulated radiation therapy: A planning technique to reduce normal tissue toxicity.
López Alfonso JC; Parsai S; Joshi N; Godley A; Shah C; Koyfman SA; Caudell JJ; Fuller CD; Enderling H; Scott JG
Med Phys; 2018 Jul; 45(7):3466-3474. PubMed ID: 29786861
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric comparison of intensity-modulated radiation therapy for early-stage glottic cancers with and without the air cavity in the planning target volume.
Asher D; Amestoy W; Studenski MT; Samuels SE; Abramowitz MC; Freedman LM; Elsayyad N; Samuels MA
Med Dosim; 2019 Winter; 44(4):405-408. PubMed ID: 30928177
[TBL] [Abstract][Full Text] [Related]
38. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
39. Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicity.
Hoppe BS; Wolden SL; Zelefsky MJ; Mechalakos JG; Shah JP; Kraus DH; Lee N
Head Neck; 2008 Jul; 30(7):925-32. PubMed ID: 18302261
[TBL] [Abstract][Full Text] [Related]
40. Long-Term Pulmonary Outcomes of a Feasibility Study of Inverse-Planned, Multibeam Intensity Modulated Radiation Therapy in Node-Positive Breast Cancer Patients Receiving Regional Nodal Irradiation.
Ho AY; Ballangrud A; Li G; Gupta GP; McCormick B; Gewanter R; Gelblum D; Zinovoy M; Mueller B; Mychalczak B; Dutta P; Borofsky K; Parhar P; Reyngold M; Braunstein LZ; Chawla M; Krause K; Freeman N; Siu CT; Cost Z; Arnold BB; Zhang Z; Powell SN
Int J Radiat Oncol Biol Phys; 2019 Apr; 103(5):1100-1108. PubMed ID: 30508620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
